Direct-To-Consumer Genetics and Health Policy: A Worst-Case Scenario?

American Journal of Bioethics 9 (6-7):48-50 (2009)
  Copy   BIBTEX

Abstract

There is currently little evidence that the information provided by personal genomics companies—such as 23andMe and Navigenics—on a direct-to-consumer (DTC) basis, has any real health value. To be...

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,322

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

The structure of argumentation in health product messages.Douglas Walton - 2010 - Argument and Computation 1 (3):179-198.
Consumer Rights: An Assessment of Justice. [REVIEW]Gretchen Larsen & Rob Lawson - 2013 - Journal of Business Ethics 112 (3):515-528.
Why 'health' is not a central category for public health policy.Stephen John - 2009 - Journal of Applied Philosophy 26 (2):129-143.
Why health is not special: Errors in evolved bioethics intuitions.Robin Hanson - 2002 - Social Philosophy and Policy 19 (2):153-179.

Analytics

Added to PP
2010-09-14

Downloads
16 (#880,136)

6 months
6 (#522,885)

Historical graph of downloads
How can I increase my downloads?